Academic Journal
Q1International Journal of Cancer
About International Journal of Cancer
International Journal of Cancer is a scholarly journal published by John Wiley and Sons Inc. SCImago 2025 places it in Q1 with an SJR of 1.901 and an H-index of 275.
Its listed coverage is 1966-2026 and its research categories include Cancer Research (Q1); Oncology (Q1). The 2025 dataset reports 479 documents and 6177 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research, Genetic factors in colorectal cancer, Cervical Cancer and HPV Research, Cancer-related Molecular Pathways.
Recent Research Articles
Latest publications matched automatically by ISSN.
Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long‐Term Survival Outcomes
Thierry Alcindor, James Tankel, Pierre‐Olivier Fiset, Mehrnoush Dehghani et al.
2026-09-17 · DOI: 10.1002/ijc.70749Trends in Incidence Rates of Anogenital Cancers in Costa Rica, 1996–2022
Loretto J. Carvajal, Jaimie Z. Shing, Juan Carlos Vanegas, Rebeca Ocampo et al.
2026-09-15 · DOI: 10.1002/ijc.70664Heterogeneity in Postoperative Survival Benefit Associated With Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma: A Causal Survival Forest Analysis
Xuezhong Shi, Wenjing Xu, Yanpeng Wu, Yongli Yang et al.
2026-09-15 · DOI: 10.1002/ijc.70729Comments on “Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma”
Chen‐Guang Liu, Junyuan Yang, Ruijun Luo, Rui Sun et al.
2026-09-11 · DOI: 10.1002/ijc.70702Incidence and Predictors of Immune‐Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real‐World Cohort Study
Freya Koffka, Johann Kornowski, Elena Laakmann, Barbara Schmalfeldt et al.
2026-09-10 · DOI: 10.1002/ijc.70735Comparative Effectiveness of Induction Chemotherapy Regimens in Pediatric and Adolescent Locally Advanced Nasopharyngeal Carcinoma: A Retrospective IPTW Analysis
Rui‐Ling Xie, Ye‐Hao Zou, Zi‐Xuan Chen, Ling‐Ling Zhang et al.
2026-09-10 · DOI: 10.1002/ijc.70724Perioperative Rehabilitation and Initiation of Adjuvant Chemotherapy in Resected Non‐Small Cell Lung Cancer
Shinkichi Takamori, Tateaki Naito, Nobuko Konishi, Tetsuya Tsuji et al.
2026-09-10 · DOI: 10.1002/ijc.70709Early Cessation of Adjuvant Anti‐ PD ‐1 Therapy in Stage III and IV Melanoma
Manja Bloem, Melissa M. de Meza, Cato D. M. Boreel, Maureen J. B. Aarts et al.
2026-09-09 · DOI: 10.1002/ijc.70738Is Less More? An Update on Aspirin for Cancer Prevention in Lynch Syndrome From the Cancer Prevention Programme— CaPP
John Burn, D. Timothy Bishop
2026-09-09 · DOI: 10.1002/ijc.70714Hot Drinks and Oesophageal Cancer: Prospective Analyses in Around 1 Million UK Adults
Keren Papier, Kezia Gaitskell, Sarah Floud, Gillian K. Reeves et al.
2026-09-08 · DOI: 10.1002/ijc.70654Germline Cancer Predisposition and De Novo Contributions in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group
Taylor M. Luckie, Sarah Scollon, Yao Yu, Aniko Sabo et al.
2026-09-08 · DOI: 10.1002/ijc.70705Impact of Single‐Cell RNA Reference Selection for the Deconvolution of Breast Cancer Spatial Transcriptomics Datasets
Stefan Altendorfer, Scott J. Walker, Carsten O. Daub
2026-09-08 · DOI: 10.1002/ijc.70733Cardiometabolic Health and Risk of Breast Cancer Subtypes Among US Black Women
Yifei Shan, Sarah M. Rothbard, Lynn Rosenberg, Julie R. Palmer et al.
2026-09-07 · DOI: 10.1002/ijc.70734Lung Cancer Risk Assessment Beyond Smoking History
Sam Hanash
2026-09-07 · DOI: 10.1002/ijc.70713Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
Hao‐Shen Cheng, Irini Yacoub, Winston Wong, Lara A. Dunn et al.
2026-09-07 · DOI: 10.1002/ijc.70723Issue Information
2026-11-01 · DOI: 10.1002/ijc.70728Reviews
Community Reviews
Version History
September 8, 2026 at 12:03 am
September 8, 2026